EPO Patents = 5

Forward Citations = 71

Loading Chart...

11 inventors (with patents filed for the assignee):

Pierre Roy (3 out of 53 patents)

Michel Paques (3 out of 4 patents)

Caroline Leriche (2 out of 10 patents)

4. David Middlemiss (2 out of 21 patents)

5. John Thomas Feutrill (1 out of 12 patents)

6. Eric Auclair (1 out of 1 patent)

7. Jacques Le Roux (1 out of 1 patent)

8. Pierre Belichard (1 patent)

9. Didier Pruneau (0 patent)

10. José Sahel (0 patent)

11. Sebastien Bonnel (0 patent)

5 patents: Sort by Forward Citations

1. 9308125 - Apparatus for intra-ocular injection (2016-04-12),

2. 9249085 - Aniline derivatives, their preparation and their therapeutic application (2016-02-02),

3. 8808242 - Apparatus for injection into an eye (2014-08-19),

4. 8460242 - Apparatus for intra-ocular injection (2013-06-11),

5. 8389530 - Substituted quinazoline compounds (2013-03-05),

Fovea Pharmaceuticals is a leading biopharmaceutical company dedicated to developing innovative treatments for sight-threatening diseases. With a focus on retinal disorders, Fovea's cutting-edge research and development efforts aim to improve the quality of life for patients worldwide. Through strategic partnerships and collaborations with top scientists and healthcare professionals, Fovea is committed to delivering breakthrough therapies that address unmet medical needs in the field of ophthalmology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#531 in Paris

#2,811 in France

Paris, France

Fovea Pharmaceuticals